LexisNexis‘ risk solutions practice has earned certification from SAFE-BioPharma Association on the capability of its identity credentials to manage access to personal and sensitive information.
Kim Little Sutherland, senior director for identity management at LexisNexis, said Monday that this highlights the company’s identity management and multifactor authentication solutions for both government and healthcare organizations.
The accreditation covers LexisNexis Instant Authenticate, Multi-Factor Authentication, InstantID and InstantID Q&A solutions, the company said.
LexisNexis is an Identity Proofing Component member of SAFE-BioPharma’s trust framework.
The SAFE-BioPharma Association is a government-approved Trust Framework Provider under the Federal Identity, Credential and Access Management program.